DE3789316D1 - Herstellung von human-parathyroidhormon. - Google Patents

Herstellung von human-parathyroidhormon.

Info

Publication number
DE3789316D1
DE3789316D1 DE87906915T DE3789316T DE3789316D1 DE 3789316 D1 DE3789316 D1 DE 3789316D1 DE 87906915 T DE87906915 T DE 87906915T DE 3789316 T DE3789316 T DE 3789316T DE 3789316 D1 DE3789316 D1 DE 3789316D1
Authority
DE
Germany
Prior art keywords
parathyroidhormone
human
production
human parathyroidhormone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE87906915T
Other languages
English (en)
Other versions
DE3789316T2 (de
Inventor
Kaare Gautvik
Oyen Tordis Beate
Odd Gabrielsen
Peter Alestrom
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
SELMER SANDE AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SELMER SANDE AS filed Critical SELMER SANDE AS
Application granted granted Critical
Publication of DE3789316D1 publication Critical patent/DE3789316D1/de
Publication of DE3789316T2 publication Critical patent/DE3789316T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/635—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/64—General methods for preparing the vector, for introducing it into the cell or for selecting the vector-containing host
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/66—General methods for inserting a gene into a vector to form a recombinant vector using cleavage and ligation; Use of non-functional linkers or adaptors, e.g. linkers containing the sequence for a restriction endonuclease
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Endocrinology (AREA)
  • Mycology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE3789316T 1986-10-22 1987-10-07 Herstellung von human-parathyroidhormon. Expired - Lifetime DE3789316T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US92168486A 1986-10-22 1986-10-22
PCT/EP1987/000581 WO1988003165A1 (en) 1986-10-22 1987-10-07 Production of human parathyroid hormone from microorganisms

Publications (2)

Publication Number Publication Date
DE3789316D1 true DE3789316D1 (de) 1994-04-14
DE3789316T2 DE3789316T2 (de) 1994-08-25

Family

ID=25445824

Family Applications (2)

Application Number Title Priority Date Filing Date
DE3789316T Expired - Lifetime DE3789316T2 (de) 1986-10-22 1987-10-07 Herstellung von human-parathyroidhormon.
DE3752375T Active DE3752375T8 (de) 1986-10-22 1987-10-07 Herstellung von humanem Parathormon

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE3752375T Active DE3752375T8 (de) 1986-10-22 1987-10-07 Herstellung von humanem Parathormon

Country Status (7)

Country Link
US (1) US6962796B1 (de)
EP (3) EP1114865B1 (de)
JP (3) JP2777132B2 (de)
AU (2) AU627147B2 (de)
DE (2) DE3789316T2 (de)
HK (1) HK68497A (de)
WO (1) WO1988003165A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE37919E1 (en) 1989-05-12 2002-12-03 The General Hospital Corporation Recombinant DNA method for production of parathyroid hormone
US5171670A (en) * 1989-05-12 1992-12-15 The General Hospital Corporation Recombinant dna method for production of parathyroid hormone
AU6448990A (en) * 1989-09-29 1991-04-28 Her Majesty in Right of Canada, as represented by National Research Council Canada Synthesis of mature human parathyroid hormone
DE69111371T2 (de) * 1990-09-28 1996-03-14 Takeda Chemical Industries Ltd Synthetisches Gen für menschliches Parathyroidhormon.
ATE152127T1 (de) * 1991-08-07 1997-05-15 Takeda Chemical Industries Ltd Muteine des menschlichen parathormons und ihre herstellung
JPH05271279A (ja) * 1991-08-07 1993-10-19 Takeda Chem Ind Ltd ヒト副甲状腺ホルモンムテインおよびその製造法
US5382658A (en) * 1992-04-03 1995-01-17 Allelix Biopharmaceuticals Inc. Stability-enhanced variants of parathyroid hormone
CA2098639A1 (en) * 1992-06-19 1993-12-20 K. Anne Kronis Bone stimulating, non-vasoactive parathyroid hormone variants
US6794357B1 (en) 1993-06-24 2004-09-21 Astrazeneca Ab Compositions for inhalation
US5830853A (en) 1994-06-23 1998-11-03 Astra Aktiebolag Systemic administration of a therapeutic preparation
US6632456B1 (en) 1993-06-24 2003-10-14 Astrazeneca Ab Compositions for inhalation
US6524557B1 (en) 1994-12-22 2003-02-25 Astrazeneca Ab Aerosol formulations of peptides and proteins
KR100386836B1 (ko) * 2000-08-31 2003-06-09 동국제약 주식회사 재조합 인체 부갑상선 호르몬을 생산하는 형질전환효모 및재조합 인체 부갑상선 호르몬의 생산방법
EP1985628A1 (de) * 2007-04-05 2008-10-29 SYMBIOTEC Gesellschaft zur Forschung und Entwicklung auf dem Gebiet der Biotechnologie mbH Bis-Met-Histone
JP5634259B2 (ja) * 2007-04-05 2014-12-03 シンバイオテック ゲゼルシャフト ツーア フォルシュング ウント エントヴィックルング アウフ デム ゲビート デア ビオテヒノロギー ミット ベシュレンクテル ハフツング Ｂｉｓ−ｍｅｔヒストン

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3886132A (en) 1972-12-21 1975-05-27 Us Health Human parathyroid hormone
US4468464A (en) 1974-11-04 1984-08-28 The Board Of Trustees Of The Leland Stanford Junior University Biologically functional molecular chimeras
US4237224A (en) 1974-11-04 1980-12-02 Board Of Trustees Of The Leland Stanford Jr. University Process for producing biologically functional molecular chimeras
US4264731A (en) 1977-05-27 1981-04-28 The Regents Of The University Of California DNA Joining method
US4366246A (en) 1977-11-08 1982-12-28 Genentech, Inc. Method for microbial polypeptide expression
US4425437A (en) 1979-11-05 1984-01-10 Genentech, Inc. Microbial polypeptide expression vehicle
US4338397A (en) 1980-04-11 1982-07-06 President And Fellows Of Harvard College Mature protein synthesis
US4383066A (en) 1980-04-15 1983-05-10 Mitsubishi Gas Chemical Company, Inc. Polyphenylene ether resin composition
JPS5825439B2 (ja) 1980-12-30 1983-05-27 株式会社林原生物化学研究所 ヒト副甲状腺ホルモンの製造方法
US4394443A (en) 1980-12-18 1983-07-19 Yale University Method for cloning genes
US4624926A (en) 1981-01-02 1986-11-25 The Research Foundation Of State University Of New York Novel cloning vehicles for polypeptide expression in microbial hosts
NO163060C (no) 1981-03-13 1990-03-28 Damon Biotech Inc Fremgangsmaate for fremstilling av substanser som dannes av levende celler som produserer interferoner eller antistoffer.
US4532207A (en) 1982-03-19 1985-07-30 G. D. Searle & Co. Process for the preparation of polypeptides utilizing a charged amino acid polymer and exopeptidase
US4546082A (en) * 1982-06-17 1985-10-08 Regents Of The Univ. Of California E. coli/Saccharomyces cerevisiae plasmid cloning vector containing the alpha-factor gene for secretion and processing of hybrid proteins
EP0119247A1 (de) * 1982-09-15 1984-09-26 Immuno Nuclear Corporation Herstellung reifer proteine in transformierter hefe
DE3312928A1 (de) 1983-04-11 1984-11-22 Gesellschaft für Biotechnologische Forschung mbH (GBF), 3300 Braunschweig Human-parathormon produzierende hybridvektoren und human-parathormongen
NZ207926A (en) 1983-04-25 1988-04-29 Genentech Inc Use of yeast #a#-factor to assist in expression of proteins heterologus to yeast
US4588684A (en) 1983-04-26 1986-05-13 Chiron Corporation a-Factor and its processing signals
CA1213537A (en) 1984-05-01 1986-11-04 Canadian Patents And Development Limited - Societe Canadienne Des Brevets Et D'exploitation Limitee Polypeptide expression method
US5420242A (en) * 1986-10-22 1995-05-30 Kaare M. Gautvik Production of human parathyroid hormone from microorganisms
US5010010A (en) 1986-10-22 1991-04-23 Selmer-Sande, A.S. Production of human parathyroid hormone from microorganisms
US5171670A (en) 1989-05-12 1992-12-15 The General Hospital Corporation Recombinant dna method for production of parathyroid hormone
USRE37919E1 (en) * 1989-05-12 2002-12-03 The General Hospital Corporation Recombinant DNA method for production of parathyroid hormone

Also Published As

Publication number Publication date
JP2828427B2 (ja) 1998-11-25
JP2834111B2 (ja) 1998-12-09
DE3752375T8 (de) 2005-03-10
EP0383751A1 (de) 1990-08-29
JPH02501108A (ja) 1990-04-19
DE3789316T2 (de) 1994-08-25
AU8104887A (en) 1988-05-25
EP0604706A1 (de) 1994-07-06
EP1114865A1 (de) 2001-07-11
EP0383751B1 (de) 1994-03-09
DE3752375T2 (de) 2004-10-21
WO1988003165A1 (en) 1988-05-05
JPH1014587A (ja) 1998-01-20
EP1114865B1 (de) 2004-01-21
HK68497A (en) 1997-05-30
US6962796B1 (en) 2005-11-08
JPH09110899A (ja) 1997-04-28
AU665034B2 (en) 1995-12-14
AU627147B2 (en) 1992-08-20
JP2777132B2 (ja) 1998-07-16
DE3752375D1 (de) 2004-02-26
AU2851692A (en) 1993-04-08

Similar Documents

Publication Publication Date Title
DE3780933D1 (de) Herstellung von aminoalanen.
ATE72660T1 (de) Herstellung von zeolith-l.
DE3675169D1 (de) Herstellung von tabletten.
DE3872495D1 (de) Herstellung von 3,3,3-trifluoropropen.
DE3786091D1 (de) Herstellung tomographischer abbildungen.
DE3789316D1 (de) Herstellung von human-parathyroidhormon.
DE3766559D1 (de) Herstellung von kristallinem tribromstyrol.
DE3683660D1 (de) Herstellung von halogenierten benzolen.
DE69213447D1 (de) Herstellung von n-acylimidazolen
ATE38211T1 (de) Herstellung von zeolith-l.
DE3778134D1 (de) Kontinuierliche herstellung von dialkansulfonylperoxiden.
DE3876769D1 (de) Mikrobiologische herstellung von 9-alpha-hydroxy-17-keto-steroiden.
DE3770889D1 (de) Herstellung von kubischem bornitrid.
DE68921340D1 (de) Herstellung von epoxinitraten.
DE3875281D1 (de) Herstellung von pseudoiononen.
DE3773028D1 (de) Herstellung von zimtsaeuren.
DE3870723D1 (de) Herstellung von ascorbinsaeure-6-estern.
DE3585097D1 (de) Herstellung menschlicher urokinase.
DE3851903D1 (de) Herstellung von Tabletten.
DE3582003D1 (de) Herstellung von glycolmonoestern.
DE3768168D1 (de) Selektive herstellung von cis-perhydroacenaphthen.
DE69002496D1 (de) Herstellung von fluorphenolen.
DE3886890D1 (de) Herstellung von modifizierten Polysiloxanen.
DE3670063D1 (de) Herstellung von thioantimonaten.
DE3766873D1 (de) Herstellung von substituierten dichlormethylpyridinen.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: GAUTVIK, KAARE M., DR., OSLO, NO ALESTROM, PETER,

8327 Change in the person/name/address of the patent owner

Owner name: ASTRA AB, SOEDERTAELJE, SE